Artificial Intelligence (AI) in Radiation Dosing Market by Type of Modalities (Computed Tomography, CT Scan, MRI, Mammography, X-ray, Ultrasound and Others); By End User (Hospitals, Diagnostic Center, Medical Institutions, Other Medical Groups); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027

Report ID :AMI-263 | Category : Healthcare And IT | Published Date : August, 2019 | Pages : 210 | Format :PDF
Buy Now!

Industry Trends

Artificial Intelligence (AI) in Radiation Dosing along with its subset deep learning technology provides distinct images for the modalities performed in various healthcare settings. The same provides low dosage radiations among the patient group. This technology pioneers the use of medical scans to derive appropriate radiation dosage, hence augmenting the field forward from using generic dose prescriptions. AI in Radiation dosing has its application in clinics, hospitals, diagnostic centers and research centers.

Without leveraging AI, radiation therapy can only be delivered uniformly which is not capable of reflecting differences in patient-specific factors such as individual tumor characteristics that may affect treatment success. This drawback is one of the primary factors driving the growth of the AI in Radiation dosing market. AI framework accounts for the variability that can reduce the treatment failure probability to less than 5 percent through personalized radiation doses. It helps physicians to develop data-driven, personalized dosage schedules that can maximize the probability of treatment success and mitigate radiation side effects for patients. This approach is anticipated to greatly benefit the field of radiotherapy with advanced dose optimization capabilities.

The development of AI in Radiation dosing is encouraging not only because it uses medical images to inform radiation dose prescriptions, but it also has the potential to strengthen holistic patient care. It provides the ability to individualize multiple cancer therapies and being viewed as a leap forward towards radiation precision medicine. For instance, France-based manufacturer of contrast agents, Guerbet LLC has entered a commercial partnership with Imalogix. The commercial partnership aims at identification of impact care delivery areas by combining Imalogix’s cloud-based human and machine-intelligence capabilities with Guerbet's capabilities in diagnostic and interventional imaging.

AI in Radiation dosing is resolving a significant issue for patients undergoing CT scans. Over the past several years, companies are making significant efforts to alleviate concerns about patient exposure to X-ray radiation associated with widely used CT scans. Machine learning and deep learning techniques have the ability to enable low radiation dose while producing higher quality scans compared to traditional reconstruction techniques.

In terms of revenue, the AI in Radiation dosing market stood at US$ 39.222 Mn in 2018, and is expected to grow at a CAGR of 30.2% during the forecast period of 2019 - 2027. The study analyzes the market in terms of revenue across all the major regions, which is further bifurcated into countries.  

North America, AI in Radiation Dosing Market Revenue & Forecast, (US$ Million), 2015 – 2027

AI in Radiation Dosing Market

Competitive Landscape

The report provides both, qualitative and quantitative research of AI in Radiation Dosing market, as well as provides comprehensive insights and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings, specification, pricing, and gross margin.

Some of the players operating in the AI in Radiation Dosing market are Bayer AG, Imalogix, Siemens Healthcare, Omega Medical Imaging, LLC, and icometrix amongst others.

AI in Radiation Dosing Market:

  • By Type of Modalities
    • Computed Tomography
    • (CT) Scan
    • MRI
    • Mammography
    • X-ray
    • Ultrasound
    • Others
  • By End User
    • Hospitals
    • Diagnostic Center
    • Medical Institutions
    • Other Medical Groups
  • By Geography
    • North America
      • U.S.
      • Canada
      • Mexico
      • Rest of North America
    • Europe
      • France
      • The UK
      • Spain
      • Germany
      • Italy
      • Nordic Countries
      • Benelux Union
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • New Zealand
      • Australia
      • South Korea
      • Southeast Asia
        • Indonesia
        • Thailand
        • Malaysia
        • Singapore
        • Rest of Southeast Asia
      • Rest of Asia Pacific
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Egypt
      • Kuwait
      • South Africa
      • Rest of Middle East & Africa
    • Latin America
      • Argentina
      • Brazil
      • Rest of Latin America

Key Questions

Request Sample

Report Customization

Request for Customization

1.    Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Base Year: 2018

1.2.2. Forecast Years: 2019 – 2027

2.    Key Target Audiences

3.    Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of AI in Radiation Dosing Market

6.    Market Synopsis:  AI in Radiation Dosing Market

7.    AI in Radiation Dosing Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.2.4. Challenges

7.3. Trends in AI in Radiation Dosing Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: AI in Radiation Dosing Market

7.6. Porter’s Five Force Analysis

7.7. Analysis of Technological Innovations in AI in Radiation Dosing Market

8.    Global AI in Radiation Dosing Market Analysis and Forecasts, 2019 – 2027

8.1. Overview

8.1.1. Global AI in Radiation Dosing Market Revenue (US$ Mn)

8.2. Global AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

8.2.1. Ultrasound

8.2.1.1. Definition

8.2.1.2. Market Penetration, 2018

8.2.1.3. Market Estimation, 2018

8.2.1.4. Market Forecast, 2019 – 2027

8.2.1.5. Compound Annual Growth Rate (CAGR)

8.2.1.6. Regional Bifurcation

8.2.1.6.1. North America

8.2.1.6.1.1. Market Estimation, 2018

8.2.1.6.1.2. Market Forecast, 2019 – 2027

8.2.1.6.2. Europe

8.2.1.6.2.1. Market Estimation, 2018

8.2.1.6.2.2. Market Forecast, 2019 – 2027

8.2.1.6.3. Asia Pacific

8.2.1.6.3.1. Market Estimation, 2018

8.2.1.6.3.2. Market Forecast, 2019 – 2027

8.2.1.6.4. Middle East and Africa

8.2.1.6.4.1. Market Estimation, 2018

8.2.1.6.4.2. Market Forecast, 2019 – 2027

8.2.1.6.5. Latin America

8.2.1.6.5.1. Market Estimation, 2018

8.2.1.6.5.2. Market Forecast, 2019 – 2027

8.2.2. X-Ray

8.2.2.1. Definition

8.2.2.2. Market Penetration, 2018

8.2.2.3. Market Estimation, 2018

8.2.2.4. Market Forecast, 2019 – 2027

8.2.2.5. Compound Annual Growth Rate (CAGR)

8.2.2.6. Regional Bifurcation

8.2.2.6.1. North America

8.2.2.6.1.1. Market Estimation, 2018

8.2.2.6.1.2. Market Forecast, 2019 – 2027

8.2.2.6.2. Europe

8.2.2.6.2.1. Market Estimation, 2018

8.2.2.6.2.2. Market Forecast, 2019 – 2027

8.2.2.6.3. Asia Pacific

8.2.2.6.3.1. Market Estimation, 2018

8.2.2.6.3.2. Market Forecast, 2019 – 2027

8.2.2.6.4. Middle East and Africa

8.2.2.6.4.1. Market Estimation, 2018

8.2.2.6.4.2. Market Forecast, 2019 – 2027

8.2.2.6.5. Latin America

8.2.2.6.5.1. Market Estimation, 2018

8.2.2.6.5.2. Market Forecast, 2019 – 2027

8.2.3. MRI

8.2.3.1. Definition

8.2.3.2. Market Penetration, 2018

8.2.3.3. Market Estimation, 2018

8.2.3.4. Market Forecast, 2019 – 2027

8.2.3.5. Compound Annual Growth Rate (CAGR)

8.2.3.6. Regional Bifurcation

8.2.3.6.1. North America

8.2.3.6.1.1. Market Estimation, 2018

8.2.3.6.1.2. Market Forecast, 2019 – 2027

8.2.3.6.2. Europe

8.2.3.6.2.1. Market Estimation, 2018

8.2.3.6.2.2. Market Forecast, 2019 – 2027

8.2.3.6.3. Asia Pacific

8.2.3.6.3.1. Market Estimation, 2018

8.2.3.6.3.2. Market Forecast, 2019 – 2027

8.2.3.6.4. Middle East and Africa

8.2.3.6.4.1. Market Estimation, 2018

8.2.3.6.4.2. Market Forecast, 2019 – 2027

8.2.3.6.5. Latin America

8.2.3.6.5.1. Market Estimation, 2018

8.2.3.6.5.2. Market Forecast, 2019 – 2027

8.2.4. CT Scan

8.2.4.1. Definition

8.2.4.2. Market Penetration, 2018

8.2.4.3. Market Estimation, 2018

8.2.4.4. Market Forecast, 2019 – 2027

8.2.4.5. Compound Annual Growth Rate (CAGR)

8.2.4.6. Regional Bifurcation

8.2.4.6.1. North America

8.2.4.6.1.1. Market Estimation, 2018

8.2.4.6.1.2. Market Forecast, 2019 – 2027

8.2.4.6.2. Europe

8.2.4.6.2.1. Market Estimation, 2018

8.2.4.6.2.2. Market Forecast, 2019 – 2027

8.2.4.6.3. Asia Pacific

8.2.4.6.3.1. Market Estimation, 2018

8.2.4.6.3.2. Market Forecast, 2019 – 2027

8.2.4.6.4. Middle East and Africa

8.2.4.6.4.1. Market Estimation, 2018

8.2.4.6.4.2. Market Forecast, 2019 – 2027

8.2.4.6.5. Latin America

8.2.4.6.5.1. Market Estimation, 2018

8.2.4.6.5.2. Market Forecast, 2019 – 2027

8.2.5. Mammography

8.2.5.1. Definition

8.2.5.2. Market Penetration, 2018

8.2.5.3. Market Estimation, 2018

8.2.5.4. Market Forecast, 2019 – 2027

8.2.5.5. Compound Annual Growth Rate (CAGR)

8.2.5.6. Regional Bifurcation

8.2.5.6.1. North America

8.2.5.6.1.1. Market Estimation, 2018

8.2.5.6.1.2. Market Forecast, 2019 – 2027

8.2.5.6.2. Europe

8.2.5.6.2.1. Market Estimation, 2018

8.2.5.6.2.2. Market Forecast, 2019 – 2027

8.2.5.6.3. Asia Pacific

8.2.5.6.3.1. Market Estimation, 2018

8.2.5.6.3.2. Market Forecast, 2019 – 2027

8.2.5.6.4. Middle East and Africa

8.2.5.6.4.1. Market Estimation, 2018

8.2.5.6.4.2. Market Forecast, 2019 – 2027

8.2.5.6.5. Latin America

8.2.5.6.5.1. Market Estimation, 2018

8.2.5.6.5.2. Market Forecast, 2019 – 2027

8.2.6. Others

8.2.6.1. Definition

8.2.6.2. Market Penetration, 2018

8.2.6.3. Market Estimation, 2018

8.2.6.4. Market Forecast, 2019 – 2027

8.2.6.5. Compound Annual Growth Rate (CAGR)

8.2.6.6. Regional Bifurcation

8.2.6.6.1. North America

8.2.6.6.1.1. Market Estimation, 2018

8.2.6.6.1.2. Market Forecast, 2019 – 2027

8.2.6.6.2. Europe

8.2.6.6.2.1. Market Estimation, 2018

8.2.6.6.2.2. Market Forecast, 2019 – 2027

8.2.6.6.3. Asia Pacific

8.2.6.6.3.1. Market Estimation, 2018

8.2.6.6.3.2. Market Forecast, 2019 – 2027

8.2.6.6.4. Middle East and Africa

8.2.6.6.4.1. Market Estimation, 2018

8.2.6.6.4.2. Market Forecast, 2019 – 2027

8.2.6.6.5. Latin America

8.2.6.6.5.1. Market Estimation, 2018

8.2.6.6.5.2. Market Forecast, 2019 – 2027

8.3. Key Segment for Channeling Investments

8.3.1. By Modalities

9.    Global AI in Radiation Dosing Market Analysis and Forecasts, 2019 – 2027

9.1. Overview

9.2. Global AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

9.2.1. Hospitals

9.2.1.1. Definition

9.2.1.2. Market Penetration, 2018

9.2.1.3. Market Estimation, 2018

9.2.1.4. Market Forecast, 2019 – 2027

9.2.1.5. Compound Annual Growth Rate (CAGR)

9.2.1.6. Regional Bifurcation

9.2.1.6.1. North America

9.2.1.6.1.1. Market Estimation, 2018

9.2.1.6.1.2. Market Forecast, 2019 – 2027

9.2.1.6.2. Europe

9.2.1.6.2.1. Market Estimation, 2018

9.2.1.6.2.2. Market Forecast, 2019 – 2027

9.2.1.6.3. Asia Pacific

9.2.1.6.3.1. Market Estimation, 2018

9.2.1.6.3.2. Market Forecast, 2019 – 2027

9.2.1.6.4. Middle East and Africa

9.2.1.6.4.1. Market Estimation, 2018

9.2.1.6.4.2. Market Forecast, 2019 – 2027

9.2.1.6.5. Latin America

9.2.1.6.5.1. Market Estimation, 2018

9.2.1.6.5.2. Market Forecast, 2019 – 2027

9.2.2. Medical Institutions

9.2.2.1. Definition

9.2.2.2. Market Penetration, 2018

9.2.2.3. Market Estimation, 2018

9.2.2.4. Market Forecast, 2019 – 2027

9.2.2.5. Compound Annual Growth Rate (CAGR)

9.2.2.6. Regional Bifurcation

9.2.2.6.1. North America

9.2.2.6.1.1. Market Estimation, 2018

9.2.2.6.1.2. Market Forecast, 2019 – 2027

9.2.2.6.2. Europe

9.2.2.6.2.1. Market Estimation, 2018

9.2.2.6.2.2. Market Forecast, 2019 – 2027

9.2.2.6.3. Asia Pacific

9.2.2.6.3.1. Market Estimation, 2018

9.2.2.6.3.2. Market Forecast, 2019 – 2027

9.2.2.6.4. Middle East and Africa

9.2.2.6.4.1. Market Estimation, 2018

9.2.2.6.4.2. Market Forecast, 2019 – 2027

9.2.2.6.5. Latin America

9.2.2.6.5.1. Market Estimation, 2018

9.2.2.6.5.2. Market Forecast, 2019 – 2027

9.2.3. Diagnostics Centers

9.2.3.1. Definition

9.2.3.2. Market Penetration, 2018

9.2.3.3. Market Estimation, 2018

9.2.3.4. Market Forecast, 2019 – 2027

9.2.3.5. Compound Annual Growth Rate (CAGR)

9.2.3.6. Regional Bifurcation

9.2.3.6.1. North America

9.2.3.6.1.1. Market Estimation, 2018

9.2.3.6.1.2. Market Forecast, 2019 – 2027

9.2.3.6.2. Europe

9.2.3.6.2.1. Market Estimation, 2018

9.2.3.6.2.2. Market Forecast, 2019 – 2027

9.2.3.6.3. Asia Pacific

9.2.3.6.3.1. Market Estimation, 2018

9.2.3.6.3.2. Market Forecast, 2019 – 2027

9.2.3.6.4. Middle East and Africa

9.2.3.6.4.1. Market Estimation, 2018

9.2.3.6.4.2. Market Forecast, 2019 – 2027

9.2.3.6.5. Latin America

9.2.3.6.5.1. Market Estimation, 2018

9.2.3.6.5.2. Market Forecast, 2019 – 2027

9.2.4. Others

9.2.4.1. Definition

9.2.4.2. Market Penetration, 2018

9.2.4.3. Market Estimation, 2018

9.2.4.4. Market Forecast, 2019 – 2027

9.2.4.5. Compound Annual Growth Rate (CAGR)

9.2.4.6. Regional Bifurcation

9.2.4.6.1. North America

9.2.4.6.1.1. Market Estimation, 2018

9.2.4.6.1.2. Market Forecast, 2019 – 2027

9.2.4.6.2. Europe

9.2.4.6.2.1. Market Estimation, 2018

9.2.4.6.2.2. Market Forecast, 2019 – 2027

9.2.4.6.3. Asia Pacific

9.2.4.6.3.1. Market Estimation, 2018

9.2.4.6.3.2. Market Forecast, 2019 – 2027

9.2.4.6.4. Middle East and Africa

9.2.4.6.4.1. Market Estimation, 2018

9.2.4.6.4.2. Market Forecast, 2019 – 2027

9.2.4.6.5. Latin America

9.2.4.6.5.1. Market Estimation, 2018

9.2.4.6.5.2. Market Forecast, 2019 – 2027

9.3. Key Segment for Channeling Investments

9.3.1. By End User

10. North America AI in Radiation Dosing Market Analysis and Forecasts, 2019 - 2027

10.1. Overview

10.1.1. North America AI in Radiation Dosing Market Revenue (US$ Mn)

10.2. North America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

10.2.1. Ultrasound

10.2.2. X-Ray

10.2.3. MRI

10.2.4. CT Scan

10.2.5. Mammography

10.2.6. Others

10.3. North America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

10.3.1. Hospitals

10.3.2. Medical Institutions

10.3.3. Diagnostics Centers

10.3.4. Others

10.4. North America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country

10.4.1. U.S

10.4.1.1. U.S AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

10.4.1.1.1. Ultrasound

10.4.1.1.2. X-Ray

10.4.1.1.3. MRI

10.4.1.1.4. CT Scan

10.4.1.1.5. Mammography

10.4.1.1.6. Others

10.4.1.2. U.S AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

10.4.1.2.1. Hospitals

10.4.1.2.2. Medical Institutions

10.4.1.2.3. Diagnostics Centers

10.4.1.2.4. Others

10.4.2. Canada

10.4.2.1. Canada AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

10.4.2.1.1. Ultrasound

10.4.2.1.2. X-Ray

10.4.2.1.3. MRI

10.4.2.1.4. CT Scan

10.4.2.1.5. Mammography

10.4.2.1.6. Others

10.4.2.2. Canada AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

10.4.2.2.1. Hospitals

10.4.2.2.2. Medical Institutions

10.4.2.2.3. Diagnostics Centers

10.4.2.2.4. Others

10.4.3. Mexico

10.4.3.1. Mexico AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

10.4.3.1.1. Ultrasound

10.4.3.1.2. X-Ray

10.4.3.1.3. MRI

10.4.3.1.4. CT Scan

10.4.3.1.5. Mammography

10.4.3.1.6. Others

10.4.3.2. Mexico AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

10.4.3.2.1. Hospitals

10.4.3.2.2. Medical Institutions

10.4.3.2.3. Diagnostics Centers

10.4.3.2.4. Others

10.4.4. Rest of North America

10.4.4.1. Rest of North America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

10.4.4.1.1. Ultrasound

10.4.4.1.2. X-Ray

10.4.4.1.3. MRI

10.4.4.1.4. CT Scan

10.4.4.1.5. Mammography

10.4.4.1.6. Others

10.4.4.2. Rest of North America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

10.4.4.2.1. Hospitals

10.4.4.2.2. Medical Institutions

10.4.4.2.3. Diagnostics Centers

10.4.4.2.4. Others

10.5. Key Segment for Channeling Investments

10.5.1. By Country

10.5.2. By Modalities

10.5.3. By End User

11. Europe AI in Radiation Dosing Market Analysis and Forecasts, 2019 - 2027

11.1. Overview

11.1.1. Europe AI in Radiation Dosing Market Revenue (US$ Mn)

11.2. Europe AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

11.2.1. Ultrasound

11.2.2. X-Ray

11.2.3. MRI

11.2.4. CT Scan

11.2.5. Mammography

11.2.6. Others

11.3. Europe AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

11.3.1. Hospitals

11.3.2. Medical Institutions

11.3.3. Diagnostics Centers

11.3.4. Others

11.4. Europe AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country

11.4.1. France

11.4.1.1. France AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

11.4.1.1.1. Ultrasound

11.4.1.1.2. X-Ray

11.4.1.1.3. MRI

11.4.1.1.4. CT Scan

11.4.1.1.5. Mammography

11.4.1.1.6. Others

11.4.1.2. France AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

11.4.1.2.1. Hospitals

11.4.1.2.2. Medical Institutions

11.4.1.2.3. Diagnostics Centers

11.4.1.2.4. Others

11.4.2. The UK

11.4.2.1. The UK AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

11.4.2.1.1. Ultrasound

11.4.2.1.2. X-Ray

11.4.2.1.3. MRI

11.4.2.1.4. CT Scan

11.4.2.1.5. Mammography

11.4.2.1.6. Others

11.4.2.2. The UK AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

11.4.2.2.1. Hospitals

11.4.2.2.2. Medical Institutions

11.4.2.2.3. Diagnostics Centers

11.4.2.2.4. Others

11.4.3. Spain

11.4.3.1. Spain AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

11.4.3.1.1. Ultrasound

11.4.3.1.2. X-Ray

11.4.3.1.3. MRI

11.4.3.1.4. CT Scan

11.4.3.1.5. Mammography

11.4.3.1.6. Others

11.4.3.2. Spain AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

11.4.3.2.1. Hospitals

11.4.3.2.2. Medical Institutions

11.4.3.2.3. Diagnostics Centers

11.4.3.2.4. Others

11.4.4. Germany

11.4.4.1. Germany AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

11.4.4.1.1. Ultrasound

11.4.4.1.2. X-Ray

11.4.4.1.3. MRI

11.4.4.1.4. CT Scan

11.4.4.1.5. Mammography

11.4.4.1.6. Others

11.4.4.2. Germany AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

11.4.4.2.1. Hospitals

11.4.4.2.2. Medical Institutions

11.4.4.2.3. Diagnostics Centers

11.4.4.2.4. Others

11.4.5. Italy

11.4.5.1. Italy AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

11.4.5.1.1. Ultrasound

11.4.5.1.2. X-Ray

11.4.5.1.3. MRI

11.4.5.1.4. CT Scan

11.4.5.1.5. Mammography

11.4.5.1.6. Others

11.4.5.2. Italy AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

11.4.5.2.1. Hospitals

11.4.5.2.2. Medical Institutions

11.4.5.2.3. Diagnostics Centers

11.4.5.2.4. Others

11.4.6. Nordic Countries

11.4.6.1. Nordic Countries AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

11.4.6.1.1. Ultrasound

11.4.6.1.2. X-Ray

11.4.6.1.3. MRI

11.4.6.1.4. CT Scan

11.4.6.1.5. Mammography

11.4.6.1.6. Others

11.4.6.2. Nordic Countries AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

11.4.6.2.1. Hospitals

11.4.6.2.2. Medical Institutions

11.4.6.2.3. Diagnostics Centers

11.4.6.2.4. Others

11.4.6.3. Nordic Countries AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country

11.4.6.3.1. Denmark

11.4.6.3.2. Finland

11.4.6.3.3. Iceland

11.4.6.3.4. Sweden

11.4.6.3.5. Norway

11.4.7. Benelux Union

11.4.7.1. Benelux Union AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

11.4.7.1.1. Ultrasound

11.4.7.1.2. X-Ray

11.4.7.1.3. MRI

11.4.7.1.4. CT Scan

11.4.7.1.5. Mammography

11.4.7.1.6. Others

11.4.7.2. Benelux Union AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

11.4.7.2.1. Hospitals

11.4.7.2.2. Medical Institutions

11.4.7.2.3. Diagnostics Centers

11.4.7.2.4. Others

11.4.7.3. Benelux Union AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country

11.4.7.3.1. Belgium

11.4.7.3.2. The Netherlands

11.4.7.3.3. Luxembourg

11.4.8. Rest of Europe

11.4.8.1. Rest of Europe AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

11.4.8.1.1. Ultrasound

11.4.8.1.2. X-Ray

11.4.8.1.3. MRI

11.4.8.1.4. CT Scan

11.4.8.1.5. Mammography

11.4.8.1.6. Others

11.4.8.2. Rest of Europe AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

11.4.8.2.1. Hospitals

11.4.8.2.2. Medical Institutions

11.4.8.2.3. Diagnostics Centers

11.4.8.2.4. Others

11.5. Key Segment for Channeling Investments

11.5.1. By Country

11.5.2. By Modalities

11.5.3. By End User

12. Asia Pacific AI in Radiation Dosing Market Analysis and Forecasts, 2019 - 2027

12.1. Overview

12.1.1. Asia Pacific AI in Radiation Dosing Market Revenue (US$ Mn)

12.2. Asia Pacific AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

12.2.1. Ultrasound

12.2.2. X-Ray

12.2.3. MRI

12.2.4. CT Scan

12.2.5. Mammography

12.2.6. Others

12.3. Asia Pacific AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

12.3.1. Hospitals

12.3.2. Medical Institutions

12.3.3. Diagnostics Centers

12.3.4. Others

12.4. Asia Pacific AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country

12.4.1. China

12.4.1.1. China AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

12.4.1.1.1. Ultrasound

12.4.1.1.2. X-Ray

12.4.1.1.3. MRI

12.4.1.1.4. CT Scan

12.4.1.1.5. Mammography

12.4.1.1.6. Others

12.4.1.2. China AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

12.4.1.2.1. Hospitals

12.4.1.2.2. Medical Institutions

12.4.1.2.3. Diagnostics Centers

12.4.1.2.4. Others

12.4.2. Japan

12.4.2.1. Japan AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

12.4.2.1.1. Ultrasound

12.4.2.1.2. X-Ray

12.4.2.1.3. MRI

12.4.2.1.4. CT Scan

12.4.2.1.5. Mammography

12.4.2.1.6. Others

12.4.2.2. Japan AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

12.4.2.2.1. Hospitals

12.4.2.2.2. Medical Institutions

12.4.2.2.3. Diagnostics Centers

12.4.2.2.4. Others

12.4.3. India

12.4.3.1. India AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

12.4.3.1.1. Ultrasound

12.4.3.1.2. X-Ray

12.4.3.1.3. MRI

12.4.3.1.4. CT Scan

12.4.3.1.5. Mammography

12.4.3.1.6. Others

12.4.3.2. India AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

12.4.3.2.1. Hospitals

12.4.3.2.2. Medical Institutions

12.4.3.2.3. Diagnostics Centers

12.4.3.2.4. Others

12.4.4. New Zealand

12.4.4.1. New Zealand AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

12.4.4.1.1. Ultrasound

12.4.4.1.2. X-Ray

12.4.4.1.3. MRI

12.4.4.1.4. CT Scan

12.4.4.1.5. Mammography

12.4.4.1.6. Others

12.4.4.2. New Zealand AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

12.4.4.2.1. Hospitals

12.4.4.2.2. Medical Institutions

12.4.4.2.3. Diagnostics Centers

12.4.4.2.4. Others

12.4.5. Australia

12.4.5.1. Australia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

12.4.5.1.1. Ultrasound

12.4.5.1.2. X-Ray

12.4.5.1.3. MRI

12.4.5.1.4. CT Scan

12.4.5.1.5. Mammography

12.4.5.1.6. Others

12.4.5.2. Australia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

12.4.5.2.1. Hospitals

12.4.5.2.2. Medical Institutions

12.4.5.2.3. Diagnostics Centers

12.4.5.2.4. Others

12.4.6. South Korea

12.4.6.1. South Korea AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

12.4.6.1.1. Ultrasound

12.4.6.1.2. X-Ray

12.4.6.1.3. MRI

12.4.6.1.4. CT Scan

12.4.6.1.5. Mammography

12.4.6.1.6. Others

12.4.6.2. South Korea AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

12.4.6.2.1. Hospitals

12.4.6.2.2. Medical Institutions

12.4.6.2.3. Diagnostics Centers

12.4.6.2.4. Others

12.4.7. Southeast Asia

12.4.7.1. Southeast Asia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

12.4.7.1.1. Ultrasound

12.4.7.1.2. X-Ray

12.4.7.1.3. MRI

12.4.7.1.4. CT Scan

12.4.7.1.5. Mammography

12.4.7.1.6. Others

12.4.7.2. Southeast Asia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

12.4.7.2.1. Hospitals

12.4.7.2.2. Medical Institutions

12.4.7.2.3. Diagnostics Centers

12.4.7.2.4. Others

12.4.7.3. Southeast Asia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country

12.4.7.3.1. Indonesia

12.4.7.3.2. Thailand

12.4.7.3.3. Malaysia

12.4.7.3.4. Singapore

12.4.7.3.5. Rest of Southeast Asia

12.4.8. Rest of Asia Pacific

12.4.8.1. Rest of Asia Pacific AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

12.4.8.1.1. Ultrasound

12.4.8.1.2. X-Ray

12.4.8.1.3. MRI

12.4.8.1.4. CT Scan

12.4.8.1.5. Mammography

12.4.8.1.6. Others

12.4.8.2. Rest of Asia Pacific AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

12.4.8.2.1. Hospitals

12.4.8.2.2. Medical Institutions

12.4.8.2.3. Diagnostics Centers

12.4.8.2.4. Others

12.5. Key Segment for Channeling Investments

12.5.1. By Country

12.5.2. By Modalities

12.5.3. By End User

13. Middle East and Africa AI in Radiation Dosing Market Analysis and Forecasts, 2019 - 2027

13.1. Overview

13.1.1. Middle East and Africa AI in Radiation Dosing Market Revenue (US$ Mn)

13.2. Middle East and Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

13.2.1. Ultrasound

13.2.2. X-Ray

13.2.3. MRI

13.2.4. CT Scan

13.2.5. Mammography

13.2.6. Others

13.3. Middle East and Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

13.3.1. Hospitals

13.3.2. Medical Institutions

13.3.3. Diagnostics Centers

13.3.4. Others

13.4. Middle East and Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country

13.4.1. Saudi Arabia

13.4.1.1. Saudi Arabia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

13.4.1.1.1. Ultrasound

13.4.1.1.2. X-Ray

13.4.1.1.3. MRI

13.4.1.1.4. CT Scan

13.4.1.1.5. Mammography

13.4.1.1.6. Others

13.4.1.2. Saudi Arabia AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

13.4.1.2.1. Hospitals

13.4.1.2.2. Medical Institutions

13.4.1.2.3. Diagnostics Centers

13.4.1.2.4. Others

13.4.2. UAE

13.4.2.1. UAE AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

13.4.2.1.1. Ultrasound

13.4.2.1.2. X-Ray

13.4.2.1.3. MRI

13.4.2.1.4. CT Scan

13.4.2.1.5. Mammography

13.4.2.1.6. Others

13.4.2.2. UAE AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

13.4.2.2.1. Hospitals

13.4.2.2.2. Medical Institutions

13.4.2.2.3. Diagnostics Centers

13.4.2.2.4. Others

13.4.3. Egypt

13.4.3.1. Egypt AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

13.4.3.1.1. Ultrasound

13.4.3.1.2. X-Ray

13.4.3.1.3. MRI

13.4.3.1.4. CT Scan

13.4.3.1.5. Mammography

13.4.3.1.6. Others

13.4.3.2. Egypt AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

13.4.3.2.1. Hospitals

13.4.3.2.2. Medical Institutions

13.4.3.2.3. Diagnostics Centers

13.4.3.2.4. Others

13.4.4. Kuwait

13.4.4.1. Kuwait AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

13.4.4.1.1. Ultrasound

13.4.4.1.2. X-Ray

13.4.4.1.3. MRI

13.4.4.1.4. CT Scan

13.4.4.1.5. Mammography

13.4.4.1.6. Others

13.4.4.2. Kuwait AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

13.4.4.2.1. Hospitals

13.4.4.2.2. Medical Institutions

13.4.4.2.3. Diagnostics Centers

13.4.4.2.4. Others

13.4.5. South Africa

13.4.5.1. South Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

13.4.5.1.1. Ultrasound

13.4.5.1.2. X-Ray

13.4.5.1.3. MRI

13.4.5.1.4. CT Scan

13.4.5.1.5. Mammography

13.4.5.1.6. Others

13.4.5.2. South Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

13.4.5.2.1. Hospitals

13.4.5.2.2. Medical Institutions

13.4.5.2.3. Diagnostics Centers

13.4.5.2.4. Others

13.4.6. Rest of Middle East & Africa

13.4.6.1. Rest of Middle East & Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

13.4.6.1.1. Ultrasound

13.4.6.1.2. X-Ray

13.4.6.1.3. MRI

13.4.6.1.4. CT Scan

13.4.6.1.5. Mammography

13.4.6.1.6. Others

13.4.6.2. Rest of Middle East & Africa AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

13.4.6.2.1. Hospitals

13.4.6.2.2. Medical Institutions

13.4.6.2.3. Diagnostics Centers

13.4.6.2.4. Others

13.5. Key Segment for Channeling Investments

13.5.1. By Country

13.5.2. By Modalities

13.5.3. By End User

14. Latin America AI in Radiation Dosing Market Analysis and Forecasts, 2019 - 2027

14.1. Overview

14.1.1. Latin America AI in Radiation Dosing Market Revenue (US$ Mn)

14.2. Latin America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

14.2.1. Ultrasound

14.2.2. X-Ray

14.2.3. MRI

14.2.4. CT Scan

14.2.5. Mammography

14.2.6. Others

14.3. Latin America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

14.3.1. Hospitals

14.3.2. Medical Institutions

14.3.3. Diagnostics Centers

14.3.4. Others

14.4. Latin America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Country

14.4.1. Brazil

14.4.1.1. Brazil AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

14.4.1.1.1. Ultrasound

14.4.1.1.2. X-Ray

14.4.1.1.3. MRI

14.4.1.1.4. CT Scan

14.4.1.1.5. Mammography

14.4.1.1.6. Others

14.4.1.2. Brazil AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

14.4.1.2.1. Hospitals

14.4.1.2.2. Medical Institutions

14.4.1.2.3. Diagnostics Centers

14.4.1.2.4. Others

14.4.2. Argentina

14.4.2.1. Argentina AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

14.4.2.1.1. Ultrasound

14.4.2.1.2. X-Ray

14.4.2.1.3. MRI

14.4.2.1.4. CT Scan

14.4.2.1.5. Mammography

14.4.2.1.6. Others

14.4.2.2. Argentina AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

14.4.2.2.1. Hospitals

14.4.2.2.2. Medical Institutions

14.4.2.2.3. Diagnostics Centers

14.4.2.2.4. Others

14.4.3. Rest of Latin America

14.4.3.1. Rest of Latin America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By Modalities

14.4.3.1.1. Ultrasound

14.4.3.1.2. X-Ray

14.4.3.1.3. MRI

14.4.3.1.4. CT Scan

14.4.3.1.5. Mammography

14.4.3.1.6. Others

14.4.3.2. Rest of Latin America AI in Radiation Dosing Market Revenue (US$ Mn) and Forecasts, By End User

14.4.3.2.1. Hospitals

14.4.3.2.2. Medical Institutions

14.4.3.2.3. Diagnostics Centers

14.4.3.2.4. Others

14.5. Key Segment for Channeling Investments

14.5.1. By Country

14.5.2. By Modalities

14.5.3. By End User

15. Competitive Benchmarking

15.1. Market Share Analysis, 2018

15.2. Global Presence and Growth Strategies

15.2.1. Mergers and Acquisitions

15.2.2. Product Launches

15.2.3. Investments Trends

15.2.4. R&D Initiatives

16. Player Profiles

16.1. Bayer HealthCare LLC.

16.1.1. Company Details

16.1.2. Company Overview

16.1.3. Product Offerings

16.1.4. Key Developments

16.1.5. Financial Analysis

16.1.6. SWOT Analysis

16.1.7. Business Strategies

16.2. Imalogix

16.2.1. Company Details

16.2.2. Company Overview

16.2.3. Product Offerings

16.2.4. Key Developments

16.2.5. Financial Analysis

16.2.6. SWOT Analysis

16.2.7. Business Strategies

16.3. Koninklijke Philips N.V.

16.3.1. Company Details

16.3.2. Company Overview

16.3.3. Product Offerings

16.3.4. Key Developments

16.3.5. Financial Analysis

16.3.6. SWOT Analysis

16.3.7. Business Strategies

16.4. Siemens Healthcare Private Limited

16.4.1. Company Details

16.4.2. Company Overview

16.4.3. Product Offerings

16.4.4. Key Developments

16.4.5. Financial Analysis

16.4.6. SWOT Analysis

16.4.7. Business Strategies

16.5. Other Market Players

16.5.1. Company Details

16.5.2. Company Overview

16.5.3. Product Offerings

16.5.4. Key Developments

16.5.5. Financial Analysis

16.5.6. SWOT Analysis

16.5.7. Business Strategies

17. Key Findings

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology